Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...
For columnist Anna Jeter, who's now post-transplant, protecting her health during the winter in Minnesota can be challenging ...
Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.
Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...
Inhibiting the AURKB enzyme significantly improves multiple measures of blood flow in rats with pulmonary arterial ...
Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...
Cuts to federal budgets have the rare disease community on edge. Columnist Jen Cueva calls on us to unite for our future.